Related references
Note: Only part of the references are listed.Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design
David Preiss et al.
AMERICAN HEART JOURNAL (2011)
Effect of Socioeconomic Status on Mortality Among People With Type 2 Diabetes A study from the Scottish Diabetes Research Network Epidemiology Group
Jeremy J. Walker et al.
DIABETES CARE (2011)
Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
J. A. Johnson et al.
DIABETOLOGIA (2011)
Intensive glucose control and macrovascular outcomes in type 2 diabetes
F. M. Turnbull et al.
DIABETOLOGIA (2009)
Intensive glucose control and cardiovascular outcomes
John S. Yudkin et al.
LANCET (2009)
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Philip D. Home et al.
LANCET (2009)
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William Duckworth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Implementing a national quality assurance system for diabetes care: the Scottish Diabetes Survey 2001-2006
J. A. McKnight et al.
DIABETIC MEDICINE (2008)
Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study
A. Sandbaek et al.
DIABETOLOGIA (2008)
Assessing the cardiovascular safety of diabetes therapies
Allison B. Goldfine
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Increasing cardiovascular disease burden due to diabetes mellitus - The Framingham Heart Study
Caroline S. Fox et al.
CIRCULATION (2007)
Eligibility criteria of randomized controlled trials published in high-impact general medical journals - A systematic sampling review
Harriette G. C. Van Spall et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?
Justin Travers et al.
THORAX (2007)
External validity of randomized controlled trials in COPD
Justin Travers et al.
RESPIRATORY MEDICINE (2007)
Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease
Steven G. Coca et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Improvement of glycemic control in subjects with poorly controlled type 2 diabetes - Comparison of two treatment algorithms using insulin glargine
M Davies et al.
DIABETES CARE (2005)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure
FA Masoudi et al.
AMERICAN HEART JOURNAL (2003)
Representation of the elderly, women, and minorities in heart failure clinical trials
A Heiat et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Gender bias in clinical trials: Do double standards still apply?
K Ramasubbu et al.
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE (2001)